49,256
edits
Difference between revisions of "Prostate-specific antigen"
Jump to navigation
Jump to search
more
m (vauthors) |
(more) |
||
| Line 55: | Line 55: | ||
::<math>\frac{4}{3}\pi D1 \times D1 \times D3</math>. | ::<math>\frac{4}{3}\pi D1 \times D1 \times D3</math>. | ||
*As 1 cm<sup>3</sup> is equal to 1 ml, the units of PSAD are (ng/ml)/cm<sup>3</sup> or ng/ml<sup>2</sup>. | *As 1 cm<sup>3</sup> is equal to 1 ml, the units of PSAD are (ng/ml)/cm<sup>3</sup> or ng/ml<sup>2</sup>. | ||
===Phoenix definition of biochemical failure=== | |||
*PSA nadir + 2 ug/L.<ref name=pmid17968996>{{cite journal |authors=Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM |title=The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer |journal=Cancer |volume=112 |issue=1 |pages=55–60 |date=January 2008 |pmid=17968996 |doi=10.1002/cncr.23139 |url=}}</ref> | |||
===Immunostain=== | ===Immunostain=== | ||
| Line 78: | Line 81: | ||
*[[Prostate cancer]]. | *[[Prostate cancer]]. | ||
*[[Prostatic-specific acid phosphatase]]. | *[[Prostatic-specific acid phosphatase]]. | ||
*[[NKX3.1]]. | |||
==References== | ==References== | ||